Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,43719,1782,1.16 [1.08-1.25],4.762298517449362e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,43022,427,1.35 [1.17-1.55],4.442433078928591e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,47771,326,1.18 [1.00-1.40],0.0466943148510622
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,33038,1554,1.35 [1.24-1.46],2.293718183916085e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,47665,220,1.05 [0.85-1.30],0.6334175863971225
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,44593,172,1.31 [1.05-1.64],0.0168415974282523
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",50118,218,1.05 [0.85-1.29],0.6691558907202536
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,50122,147,1.01 [0.78-1.30],0.9688030027521995
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,43553,118,1.69 [1.33-2.14],1.6560841530934534e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,48494,236,1.31 [1.09-1.59],0.0046106440342075
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other septicaemia,48411,153,1.35 [1.07-1.70],0.0111284521671031
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,50281,137,1.24 [0.97-1.59],0.0921808364918425
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other viral diseases,50273,161,1.22 [0.96-1.54],0.0983943495081949
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",50262,150,1.23 [0.96-1.56],0.0950000607407944
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Mycoses,49602,104,1.35 [1.03-1.79],0.0318306487406346
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",47863,811,1.20 [1.08-1.33],0.0007646441553461
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,47331,279,1.23 [1.03-1.47],0.0229430412157644
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,47607,555,1.22 [1.08-1.39],0.0017739732480771
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",40316,125,0.86 [0.64-1.15],0.300269585238586
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",40303,112,0.84 [0.61-1.14],0.2554310228995007
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",40702,511,1.12 [0.97-1.28],0.1179021186486748
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",40716,525,1.12 [0.98-1.29],0.0914182340251384
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",22811,659,0.88 [0.77-1.00],0.0499195688228844
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",18267,228,0.92 [0.74-1.14],0.4370243190018346
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",40295,104,1.20 [0.89-1.60],0.2307625498271198
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,44917,1558,1.11 [1.03-1.21],0.0076952235202614
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",47779,642,1.04 [0.92-1.18],0.5046833119258125
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,49388,227,1.01 [0.82-1.24],0.951835578355038
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",50439,212,1.20 [0.98-1.47],0.0831045254062356
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Rectum,49894,128,0.97 [0.74-1.28],0.8435538389042665
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,50453,137,1.02 [0.78-1.34],0.8824757326007381
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Stomach,50544,104,0.95 [0.69-1.30],0.7270250247045381
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign lipomatous neoplasm,50004,585,0.97 [0.85-1.10],0.632693512455725
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,50460,215,0.95 [0.77-1.18],0.6625956399099646
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,50464,176,0.85 [0.67-1.09],0.2077966652502799
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",50347,104,0.69 [0.50-0.97],0.0301662262908183
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Haemangioma, any site",50352,103,0.71 [0.51-0.99],0.0442959302805134
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Melanocytic naevi,50190,393,1.07 [0.92-1.25],0.3868317626096654
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,50483,173,1.14 [0.91-1.44],0.2587832315902252
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Other benign neoplasms of skin,50278,361,1.13 [0.96-1.33],0.136606698021167
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm of breast,27201,135,0.87 [0.65-1.15],0.312901212099388
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Leiomyoma of uterus,26697,995,0.97 [0.88-1.08],0.6169127766523769
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,47978,382,1.21 [1.04-1.41],0.0149649640340526
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,47364,697,1.19 [1.06-1.34],0.0027531982739255
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,47364,697,1.19 [1.06-1.34],0.0027531982739255
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),43646,912,1.23 [1.11-1.36],5.727243092840069e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,49469,132,0.61 [0.45-0.82],0.0012206926006747
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,49938,166,1.39 [1.12-1.73],0.0030265545259327
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,40863,2334,1.27 [1.19-1.36],1.2411034269737828e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,47532,1066,1.16 [1.06-1.28],0.0019757563522322
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,45982,268,1.39 [1.17-1.66],0.0002174441044699
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Peripheral artery disease,48201,222,1.44 [1.20-1.74],0.0001156469443504
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,45953,239,1.38 [1.14-1.66],0.0007972382272385
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,46805,1091,1.64 [1.50-1.79],6.067143265638441e-28
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,46769,1055,1.63 [1.49-1.78],4.114747169477076e-26
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,46756,366,1.15 [0.96-1.38],0.1210104094986253
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",46759,362,1.14 [0.96-1.37],0.141184983812967
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,40522,1993,1.25 [1.16-1.35],1.1380423043729239e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",38792,263,1.37 [1.14-1.65],0.0006461608155795
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,40368,1839,1.25 [1.16-1.35],4.885496915024281e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,38626,97,1.45 [1.09-1.92],0.0101647430649342
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",38696,167,1.42 [1.14-1.76],0.0019284082637239
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Any mental disorder,42718,1281,1.27 [1.17-1.39],2.2812489208998425e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",41880,443,1.17 [1.01-1.35],0.0324755260509665
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",49748,333,1.05 [0.89-1.24],0.5585004481505331
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",49877,242,1.22 [1.01-1.46],0.0376563395943063
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,47043,113,0.93 [0.69-1.24],0.6109078522245226
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",50352,113,0.87 [0.65-1.17],0.3561051352955017
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",41550,113,0.93 [0.70-1.25],0.6489687640497444
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Alcohol dependence,47066,136,1.27 [1.00-1.62],0.0547673956026568
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Smoking dependency,46960,113,1.53 [1.18-1.99],0.0011999394480175
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",41545,108,1.48 [1.14-1.92],0.0031072583834523
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",42080,643,1.31 [1.16-1.47],5.422628941095264e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Depression,47385,561,1.28 [1.13-1.45],7.393329850343434e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Depression or dysthymia,41582,487,1.35 [1.19-1.54],4.914472272454171e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",41686,249,1.36 [1.14-1.63],0.0008628377477463
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Other anxiety disorders,47650,128,1.16 [0.89-1.52],0.2619175329043259
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Neurological diseases,43192,2907,1.17 [1.10-1.24],1.645926541841103e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,39205,255,1.32 [1.09-1.58],0.003446664414429
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,50251,204,1.29 [1.05-1.58],0.0138198292311451
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,47910,951,1.12 [1.01-1.24],0.0245859026859186
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Epilepsy,47257,298,0.77 [0.63-0.93],0.0068860793071571
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Migraine,47118,159,1.37 [1.09-1.72],0.0062502931138783
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",49959,143,1.40 [1.10-1.77],0.0054277999969409
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Transient ischemic attack,48913,157,1.36 [1.08-1.70],0.008193028998253
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other sleep disorders,47288,329,1.37 [1.16-1.60],0.0001389327672684
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Sleep apnoea,49406,251,1.37 [1.14-1.64],0.0007958154164951
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",48242,1321,1.16 [1.07-1.26],0.0006372532106177
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",47159,238,1.15 [0.95-1.40],0.1621957528143364
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,47686,765,1.13 [1.01-1.27],0.030748580709628
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,49951,161,1.20 [0.95-1.51],0.1324006244623537
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Hemiplegia,49902,112,1.21 [0.91-1.60],0.1876909256617626
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other neurological diseases,49569,237,1.19 [0.98-1.44],0.0789742789581458
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",49233,720,1.12 [1.00-1.26],0.044880560961363
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,48933,420,1.18 [1.02-1.37],0.023756952199928
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,48660,147,0.99 [0.76-1.29],0.9439383019459864
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,48750,237,1.19 [0.98-1.45],0.0786531520975081
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,48667,154,1.25 [0.99-1.59],0.0636377725819344
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,43508,316,1.14 [0.96-1.36],0.1304590392393744
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,43974,782,1.12 [1.00-1.25],0.0482676017877478
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,48565,428,1.17 [1.01-1.36],0.0345316861145538
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,49877,105,1.59 [1.22-2.06],0.0006157643535901
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,4307,105,1.26 [0.93-1.70],0.1399037210500883
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",45675,105,1.67 [1.29-2.17],0.0001019916774408
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,49198,191,1.30 [1.05-1.60],0.0139094589820137
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,49111,104,1.27 [0.96-1.70],0.0962932741450892
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",49180,171,1.07 [0.85-1.36],0.5481019438408666
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,49466,197,0.96 [0.77-1.21],0.727264616106317
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,50327,257,1.29 [1.08-1.55],0.005055969519844
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,48821,203,1.18 [0.96-1.46],0.1172281904481341
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,35787,6462,1.18 [1.13-1.24],2.941768040419632e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,49288,133,0.97 [0.74-1.27],0.8161959785006878
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Hypertension, essential",37663,4460,1.22 [1.16-1.29],1.0446854066600236e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypertension,37731,4528,1.23 [1.17-1.30],4.5882770641028334e-15
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,33357,154,1.70 [1.37-2.11],1.1405272245884596e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",46206,2360,1.27 [1.19-1.36],8.008021422959461e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Angina pectoris,45266,1420,1.24 [1.15-1.35],1.9644699349438763e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,48473,477,1.33 [1.17-1.52],2.406548700023996e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,48941,945,1.36 [1.24-1.50],1.6801511889291256e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",50280,188,1.32 [1.07-1.62],0.0098858544478589
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",44434,588,1.41 [1.25-1.59],1.9673660684196864e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,45690,1880,1.29 [1.20-1.38],1.06823137156174e-11
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Pulmonary embolism,48901,219,1.28 [1.05-1.57],0.0136235561883482
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Venous thromboembolism,49110,454,1.22 [1.06-1.40],0.0061931711793176
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Secondary right heart disease,48859,177,0.92 [0.72-1.17],0.4952260057421098
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,48861,179,0.92 [0.72-1.17],0.4928884947986833
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",33373,170,0.98 [0.77-1.26],0.8970899419694082
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Cardiomyopathy,41907,115,1.08 [0.81-1.44],0.6110221916238331
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Conduction disorders,42037,245,1.21 [1.00-1.46],0.0555999858565148
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,27887,235,1.10 [0.90-1.35],0.3588485434412167
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,28517,865,1.15 [1.03-1.29],0.0161658015550375
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other arrhythmias,41929,137,1.17 [0.91-1.52],0.2241468793274865
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,41975,183,0.81 [0.64-1.04],0.1022317888530545
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Heart failure, strict",48438,408,1.32 [1.15-1.53],0.000149270191437
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",48773,313,1.30 [1.10-1.53],0.0019986574128995
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",48836,264,1.33 [1.11-1.59],0.0016549251446592
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",48989,233,1.34 [1.11-1.62],0.002192261577762
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,48191,152,1.11 [0.87-1.42],0.402398994778165
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,48295,256,1.37 [1.15-1.63],0.0004840518671888
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),47639,279,1.21 [1.01-1.45],0.0395046579877636
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,DVT of lower extremities,47596,236,1.25 [1.03-1.51],0.0247121187158367
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",50106,225,1.25 [1.03-1.53],0.024683741079447
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Varicose veins,48289,929,0.96 [0.86-1.06],0.3993890982901117
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypotension,48170,170,1.34 [1.07-1.66],0.0093992249093904
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,40292,4053,1.17 [1.11-1.23],2.1866655343899794e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,50167,212,1.22 [1.00-1.50],0.0540980255872468
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Influenza and pneumonia,46837,436,1.24 [1.07-1.42],0.0035193510521706
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",46783,382,1.21 [1.04-1.42],0.0125236767171491
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,48682,500,1.17 [1.03-1.34],0.0199481974677717
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,48671,489,1.18 [1.03-1.35],0.0197527175604903
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,48944,1203,1.10 [1.00-1.20],0.039884129365954
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Chronic sinusitis,47925,184,0.97 [0.77-1.22],0.7891389373862578
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Nasal polyp,47984,243,1.11 [0.91-1.35],0.3113646958741349
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",48519,778,1.13 [1.02-1.26],0.0256316297064967
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Deviated nasal septum,48108,367,1.08 [0.92-1.27],0.3679771913973882
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,23212,124,1.40 [1.08-1.82],0.0100611781589549
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,45145,1990,1.17 [1.09-1.25],1.547474814673579e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Early onset COPD,48202,347,1.31 [1.12-1.53],0.0006260112043617
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",48255,400,1.23 [1.06-1.42],0.0073768025341045
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",48255,400,1.23 [1.06-1.42],0.0073768025341045
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",47131,1643,1.14 [1.06-1.23],0.0006711780526775
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Asthma,36062,1643,1.21 [1.12-1.31],1.6399564616383034e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",35542,1643,1.22 [1.12-1.31],9.465726517722596e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",36037,1618,1.20 [1.11-1.30],3.73868859476255e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,49808,185,1.21 [0.97-1.51],0.0881130733172936
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Interstitial lung disease,47632,142,1.15 [0.90-1.49],0.268997329406729
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",49959,142,1.15 [0.90-1.49],0.2668547742526989
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,47618,128,1.20 [0.92-1.56],0.1807514049256914
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Pleural effusion,46435,219,1.09 [0.88-1.34],0.4325329951481533
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other diseases of pleura,46686,470,1.09 [0.94-1.25],0.261156790793368
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,48039,215,1.16 [0.94-1.42],0.1563088926979724
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,34359,11416,1.15 [1.11-1.19],4.075274653838171e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",49506,823,1.06 [0.95-1.18],0.2953794169342409
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,50473,177,1.11 [0.88-1.40],0.3572384717956351
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Impacted teeth,50481,164,1.17 [0.92-1.48],0.1999093713999672
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Dental caries,48896,213,1.34 [1.10-1.63],0.0030598651655507
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,48880,197,0.90 [0.71-1.13],0.3450238617701087
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,50456,197,1.11 [0.89-1.38],0.3515728683762776
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,48873,190,1.03 [0.82-1.29],0.8275570128666945
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,48344,155,1.21 [0.95-1.53],0.1207703997115373
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,50310,104,1.16 [0.87-1.56],0.3173332911829045
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,38432,534,1.19 [1.04-1.35],0.0106106641142462
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",42158,4260,1.13 [1.07-1.19],2.480464025578193e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Oesophagitis,38565,667,1.18 [1.05-1.33],0.0053207531067833
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,39256,1358,1.17 [1.08-1.28],0.0001780978908415
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,38047,149,1.12 [0.88-1.44],0.3627971650716124
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,38304,406,1.18 [1.01-1.37],0.0325403433212941
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Oesophageal obstruction,38010,112,1.00 [0.74-1.35],0.996071636370484
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastric ulcer,38196,298,1.16 [0.97-1.38],0.108055641865371
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Duodenal ulcer,38142,244,1.20 [0.99-1.45],0.0595900826885196
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",50268,170,1.16 [0.92-1.45],0.2155520608276809
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Chronic gastritis,38140,242,1.06 [0.87-1.29],0.5701550745266916
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),39498,1600,1.11 [1.02-1.20],0.0117870798941847
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of appendix,50224,245,1.12 [0.93-1.37],0.2374659658533828
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Functional dyspepsia,38764,866,1.06 [0.95-1.18],0.2911601535224091
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,38230,332,1.10 [0.93-1.30],0.2643154923574959
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,50220,303,1.10 [0.92-1.31],0.3073413040298456
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Acute appendicitis,50175,196,1.06 [0.85-1.33],0.5859740485164516
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Hernia,44208,3193,1.06 [1.00-1.13],0.0380133998527381
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Inguinal hernia,42183,1168,0.98 [0.89-1.08],0.6192604155123087
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Umbilical hernia,41269,254,1.02 [0.83-1.24],0.878019887286333
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Ventral hernia,41213,198,1.08 [0.87-1.35],0.4960649969206278
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,42716,1701,1.14 [1.06-1.23],0.0007538547988146
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,48608,1489,1.17 [1.08-1.27],9.406117662925032e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of intestines,39540,3927,1.10 [1.04-1.16],0.0004155329163135
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",49866,114,1.40 [1.08-1.81],0.010537683597613
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",50397,155,1.25 [0.99-1.58],0.063336379329185
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Crohn disease,47274,155,1.26 [1.00-1.59],0.0545026520862893
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Crohn's disease NAS,47235,116,1.20 [0.91-1.58],0.1900270467184478
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",50268,267,1.02 [0.84-1.24],0.8188478146687579
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Ulcerative colitis,47386,267,1.03 [0.85-1.25],0.7410507238303561
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",47358,239,1.09 [0.89-1.33],0.4021166565583819
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,48330,1211,1.20 [1.10-1.31],3.419748486708835e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,48316,1197,1.21 [1.10-1.32],2.972761232320273e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,35805,192,1.11 [0.89-1.38],0.3695748231554486
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Intestinal stricture,49622,192,1.09 [0.87-1.36],0.4630334718723615
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",35739,126,1.05 [0.80-1.39],0.7082217989570518
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,36805,1192,1.13 [1.03-1.24],0.0092397554501269
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,35936,323,1.23 [1.04-1.45],0.0130888211269168
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,36182,569,1.19 [1.05-1.35],0.0067420504444649
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Constipation,47305,510,1.17 [1.02-1.34],0.0222614901624406
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of peritoneum,49658,170,1.44 [1.16-1.78],0.0008639260075318
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,35892,279,1.16 [0.97-1.39],0.11447358874523
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,35752,139,1.11 [0.86-1.44],0.4131691824332779
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,37331,1718,1.05 [0.97-1.13],0.2329240003084393
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of intestine,36151,538,1.09 [0.95-1.25],0.2232204460182011
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,49630,142,1.44 [1.14-1.82],0.0020863665049475
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of liver,48931,244,1.08 [0.89-1.31],0.4426052383718298
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of liver,48821,134,1.02 [0.78-1.33],0.8987408484974647
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",47836,1230,1.26 [1.16-1.37],1.652336286042793e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Cholelithiasis,47597,991,1.27 [1.15-1.39],1.311897062793037e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Cholecystitis,46801,195,1.36 [1.11-1.67],0.0035277574026542
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,46706,100,1.35 [1.02-1.80],0.0370146340026599
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Acute pancreatitis,46736,130,1.36 [1.06-1.75],0.0146493792118244
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),50189,130,1.35 [1.05-1.73],0.019674251566402
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of the digestive system,47813,618,1.32 [1.17-1.48],3.2850759605577794e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Intestinal malabsorption,47337,142,1.45 [1.15-1.82],0.0015979626343179
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Coeliac disease,47311,116,1.55 [1.21-1.97],0.0004319349120283
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",47293,98,1.39 [1.04-1.84],0.0236453019540453
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,47584,389,1.28 [1.11-1.48],0.0009880849175851
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,GI-bleeding,47570,375,1.26 [1.08-1.46],0.00279858550537
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,44325,3051,1.05 [0.99-1.11],0.1355288012031976
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,49635,198,1.07 [0.86-1.34],0.5213959409723898
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,49703,893,1.04 [0.93-1.15],0.501027238735901
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,47391,1135,1.05 [0.96-1.16],0.2855060919527434
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,48751,776,1.07 [0.96-1.20],0.2278411027015768
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",48150,175,1.11 [0.88-1.39],0.3731955178392991
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,48472,497,1.08 [0.94-1.24],0.2758844978033566
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,49978,177,1.13 [0.90-1.42],0.3015659127228972
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,49937,136,1.18 [0.91-1.52],0.2174586682482898
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,49904,103,1.24 [0.92-1.65],0.1525570627860304
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,49957,110,1.13 [0.85-1.51],0.4113555586786828
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,49952,105,1.12 [0.84-1.51],0.4371969816870882
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,48922,112,1.21 [0.92-1.61],0.1723039946510398
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,49524,714,0.99 [0.88-1.12],0.8995611147423344
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,46443,187,1.03 [0.82-1.30],0.7894352975650106
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,46451,195,0.92 [0.73-1.16],0.4980097623876152
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,46405,149,0.90 [0.69-1.17],0.4217878754312427
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",46683,427,1.08 [0.93-1.25],0.3414709058923468
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,46635,379,1.04 [0.89-1.22],0.6320538822783754
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,36362,7839,1.08 [1.04-1.13],0.0001639798470049
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,39541,4552,1.08 [1.03-1.14],0.0026283627391438
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,45549,2386,1.10 [1.03-1.18],0.0029119134977581
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,35286,297,1.28 [1.08-1.53],0.0044973949990228
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,35911,922,1.21 [1.09-1.34],0.0002600234944797
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",49698,285,1.27 [1.07-1.51],0.0072312178642025
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,49722,260,1.32 [1.11-1.58],0.0020764537994235
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,37252,2263,1.13 [1.05-1.21],0.0007622154994616
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",42316,2263,1.12 [1.04-1.20],0.0014271292272224
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,35129,140,1.13 [0.87-1.48],0.3459305156824277
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",49395,136,1.08 [0.83-1.41],0.5686545686127253
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,35432,443,1.18 [1.02-1.36],0.0281784537223631
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,35133,144,1.18 [0.91-1.52],0.207535586772368
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,35549,560,1.06 [0.92-1.21],0.4269608550979751
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",50219,277,1.00 [0.83-1.22],0.9604160598268376
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,36027,1038,1.10 [1.00-1.22],0.0611722908854751
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,35770,781,1.17 [1.05-1.31],0.0057654205137089
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,37517,2528,1.02 [0.96-1.09],0.5556007900270065
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),35117,128,1.05 [0.80-1.39],0.717747890747102
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),35454,465,0.97 [0.83-1.13],0.698354979350809
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,35099,110,0.78 [0.56-1.07],0.1251228135386864
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),35105,116,0.86 [0.63-1.17],0.3295855721836095
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,35935,946,1.01 [0.91-1.12],0.8159477749606173
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,35806,817,1.05 [0.94-1.17],0.4284753972922207
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,39087,551,1.12 [0.98-1.28],0.0879773361789885
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,49446,252,0.81 [0.66-1.00],0.0474273618494074
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,49304,110,1.20 [0.90-1.59],0.2170044152794217
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,43638,123,0.88 [0.66-1.18],0.3941501628995212
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,44094,579,1.04 [0.91-1.18],0.584910201072413
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,45346,1831,1.11 [1.03-1.20],0.0049067021835218
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,43885,370,1.09 [0.93-1.29],0.2734081869348961
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,43680,165,0.95 [0.74-1.22],0.6797492844136064
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",44961,1446,1.15 [1.06-1.24],0.0009634550270927
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,43614,99,1.13 [0.83-1.53],0.4414566291096661
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,43978,463,1.19 [1.03-1.37],0.0148440987324108
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,43711,196,1.15 [0.93-1.43],0.1961571423623954
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,43670,155,1.05 [0.82-1.35],0.7144525545870454
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,43793,278,1.11 [0.93-1.34],0.2551017964442021
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,43640,125,1.25 [0.96-1.63],0.094899031028856
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,44124,609,1.20 [1.06-1.36],0.0030891956152726
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,43779,616,1.04 [0.92-1.19],0.497391104300053
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,43297,134,0.92 [0.70-1.22],0.5724884777825086
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,43335,172,1.05 [0.82-1.33],0.7081645612163683
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,43366,203,1.12 [0.91-1.40],0.2893098099743995
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",43259,96,1.34 [1.00-1.80],0.0473825538936718
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,43391,228,0.89 [0.72-1.11],0.292268702197632
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],43364,201,0.85 [0.68-1.07],0.174413072665391
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,43685,522,1.20 [1.05-1.37],0.0079125900657435
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,43270,107,1.26 [0.95-1.67],0.1142714917095626
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,43319,156,1.11 [0.87-1.42],0.4148960807178619
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,43412,249,1.20 [0.99-1.45],0.0586246925779481
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,43285,122,0.88 [0.65-1.18],0.3775745081679497
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",44041,878,1.12 [1.01-1.25],0.0323036011103848
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,43491,328,1.02 [0.86-1.21],0.8338780328689418
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,43638,475,1.09 [0.94-1.25],0.252220858740534
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,46794,337,1.05 [0.88-1.24],0.6008176816673897
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,47227,770,1.07 [0.95-1.19],0.2642690446159662
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,46552,95,1.16 [0.85-1.58],0.3450446144199562
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,46572,115,1.00 [0.74-1.35],0.9950596333433536
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,46660,203,1.13 [0.91-1.40],0.2556981799706989
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,40075,8393,1.10 [1.06-1.14],2.042742811212623e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,20049,1262,1.10 [1.01-1.21],0.0345361660933117
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,45338,497,1.42 [1.25-1.61],6.432735734015954e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,44975,134,1.06 [0.81-1.39],0.6704117556121627
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Acute renal failure,45540,109,1.58 [1.23-2.03],0.0003591138161431
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,45567,136,1.78 [1.44-2.20],1.3648919850378854e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,45563,132,1.56 [1.23-1.96],0.0001999795598736
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Urolithiasis,49798,482,1.15 [1.00-1.32],0.0527683550009189
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,49644,140,1.47 [1.17-1.85],0.0010778267885465
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,49659,343,1.04 [0.88-1.23],0.6321572407059263
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,49487,171,1.30 [1.04-1.62],0.0216004428547637
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,46166,2056,1.12 [1.04-1.20],0.0014268983511026
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Cystitis,44305,195,1.14 [0.91-1.41],0.2528905955121753
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,44266,156,1.44 [1.15-1.80],0.001365355316762
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,44649,539,1.18 [1.04-1.35],0.0117262497672279
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Urethral stricture,44339,229,1.27 [1.05-1.55],0.015097954993174
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,45446,1336,1.14 [1.05-1.24],0.0025398295097829
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,19348,561,1.12 [0.98-1.29],0.0928399192285207
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),18891,104,1.01 [0.74-1.38],0.9421336949945468
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Hydrocele,18883,96,1.14 [0.84-1.56],0.397981416759966
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",18947,160,1.30 [1.03-1.63],0.0270124851546777
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,18945,158,1.16 [0.91-1.48],0.2286913649070642
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19001,214,0.92 [0.74-1.15],0.4649532545729228
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Disorders of breast,26940,475,0.87 [0.75-1.02],0.0801609723160661
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,26613,148,0.72 [0.54-0.94],0.0177734335349775
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,26633,168,0.89 [0.69-1.14],0.3434455016852068
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,26575,110,1.07 [0.79-1.43],0.6747513336018008
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,26876,550,1.12 [0.98-1.27],0.1047781466884018
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,26459,133,0.99 [0.75-1.30],0.9244826531016788
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,26573,247,1.28 [1.06-1.54],0.0114620396797867
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,24820,4531,1.04 [0.99-1.10],0.1260105920602941
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Endometriosis,20650,361,1.20 [1.02-1.41],0.0301010362228034
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,20388,99,1.22 [0.90-1.66],0.1946706168513373
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20454,165,1.12 [0.88-1.43],0.3569493386825023
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21063,774,1.08 [0.96-1.21],0.2088175024376324
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,20691,402,0.98 [0.84-1.15],0.8331791609823317
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21231,942,0.98 [0.88-1.09],0.6546963235649604
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20602,313,0.84 [0.70-1.01],0.0678233900218913
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",20725,436,1.05 [0.90-1.22],0.5283614012692915
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,20387,98,1.01 [0.73-1.39],0.964003414625465
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,20475,186,1.03 [0.82-1.30],0.7874026167498845
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",27217,266,1.08 [0.89-1.30],0.4560049617763539
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,27228,252,1.08 [0.89-1.31],0.4374113746507114
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,27253,138,1.08 [0.83-1.40],0.5759539796973376
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",27243,152,1.09 [0.85-1.40],0.5094615914864329
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20431,142,1.09 [0.84-1.41],0.5282855070162111
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20402,113,0.86 [0.63-1.17],0.3352394314264257
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20425,136,1.45 [1.14-1.84],0.0026497023080132
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Irregular menses,27147,464,1.04 [0.89-1.20],0.6389866969893063
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21623,1334,0.99 [0.90-1.08],0.7616064051041072
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21162,873,0.96 [0.85-1.07],0.4222293028308206
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",27233,194,0.95 [0.76-1.20],0.6686790197195966
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20742,453,0.95 [0.82-1.11],0.5509011153808514
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20611,322,1.08 [0.91-1.29],0.3695210991071911
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21180,891,0.99 [0.89-1.11],0.9272760993626106
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Female infertility,20403,114,1.21 [0.90-1.61],0.1996998878136364
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",20396,107,1.21 [0.90-1.63],0.2059069453303361
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,27250,862,1.02 [0.91-1.15],0.7220020934898548
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,27256,1182,0.98 [0.88-1.09],0.7434483943149721
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,27250,469,1.05 [0.90-1.22],0.5099082827530581
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,26918,137,1.00 [0.76-1.31],0.990330240954468
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,26965,184,1.07 [0.85-1.36],0.5626283006501036
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,26945,164,1.19 [0.93-1.51],0.1674792968132032
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",27270,167,0.94 [0.73-1.22],0.6579188018038562
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,27272,164,0.91 [0.70-1.18],0.4872170942170494
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,27267,410,1.05 [0.89-1.23],0.56836527234807
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,26981,124,0.93 [0.69-1.25],0.6289992427535225
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,27084,227,1.10 [0.88-1.36],0.4011986019492818
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,26532,144,1.36 [1.05-1.75],0.0180379634847393
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,26585,197,1.03 [0.81-1.30],0.8321178291138245
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,26633,245,0.97 [0.79-1.21],0.8020193089117938
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,26534,146,0.85 [0.64-1.13],0.2549677819415595
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,26523,135,0.99 [0.75-1.32],0.958187772756426
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,26536,148,0.73 [0.55-0.97],0.0327970550168466
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,26304,230,0.91 [0.73-1.13],0.3903965964147645
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],26502,428,1.00 [0.85-1.18],0.9581577298035828
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,26733,659,0.98 [0.85-1.12],0.7465152854323911
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",27271,171,0.94 [0.73-1.21],0.6463375977595638
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,25844,129,0.79 [0.59-1.07],0.1297237790321166
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",26178,104,0.92 [0.67-1.27],0.6074373726009301
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,27279,331,0.80 [0.66-0.96],0.0191977403280246
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,27198,250,0.81 [0.65-1.01],0.0606246786846467
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",27266,247,0.94 [0.76-1.17],0.5928044893301048
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",27256,237,0.95 [0.76-1.18],0.6223644507628983
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",49745,118,1.16 [0.88-1.53],0.2976635051752385
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Falls/tendency to fall,45514,1178,0.95 [0.87-1.05],0.3210849692026583
